Red Blood Cell Alloimmunization Is Influenced by the Delay Between Toll-Like Receptor Agonist Injection and Transfusion

Haematologica - Italy
doi 10.3324/haematol.2015.134171
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Red Cell Alloimmunization and Autoantibodies in Egyptian Transfusion-Dependent Thalassaemia Patients

Archives of Medical Science
Medicine
2010English

Responder Individuality in Red Blood Cell Alloimmunization

Transfusion Medicine and Hemotherapy
AllergyImmunologyHematology
2014English

The Future of Red Blood Cell Alloimmunization Risk Reduction

Transfusion
AllergyImmunologyHematology
2015English

A Genome-Wide Screen for Large-Effect Alloimmunization Susceptibility Loci Among Red Blood Cell Transfusion Recipients With Sickle Cell Disease

Transfusion Medicine and Hemotherapy
AllergyImmunologyHematology
2014English

Red Blood Cell Alloimmunization in Sickle Cell Disease: Listen to Your Ancestors

Transfusion Medicine and Hemotherapy
AllergyImmunologyHematology
2014English

Alloimmunization Against Rh and Kell Blood Groups Antigens Is the Main Obstacle for Blood Transfusion in Transfusion Dependent Thalassemia Patients in Iran

International Journal of Case Reports and Images
2017English

Delayed Cord Clamping in Red Blood Cell Alloimmunization: Safe, Effective, and Free?

Translational Pediatrics
Child HealthPediatricsPerinatology
2016English

Transfusion Thresholds and Other Strategies for Guiding Allogeneic Red Blood Cell Transfusion

2010English

Intravenous Delivery of the Toll-Like Receptor 7 Agonist SC1 Confers Tumor Control by Inducing a CD8+ T Cell Response

OncoImmunology
OncologyAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy